Alkermes

Alkermes Performs Better than Est.
Yahoo/Zacks.com
Fri, 02/4/11 - 11:13 am
earnings
Alkermes
JNJ
Amylin takes smaller 4Q loss as expenses decline
Yahoo/AP
Thu, 01/27/11 - 11:30 am
Amylin
earnings
Alkermes
Is Alkermes' Stock Cheap by the Numbers?
Motley Fool
Thu, 01/13/11 - 01:25 pm
Alkermes
Good News for Alkermes' Pipeline
Yahoo/Zacks.com
Thu, 12/9/10 - 12:09 pm
Alkermes
JNJ
FDA Ends October With Drug Approvals, Rejection
TheStreet.com
Mon, 11/1/10 - 08:59 am
FDA
Biodel
Avanir
Forest Labs
Arena Pharmaceuticals
Vivus
Amylin
Questcor Pharmaceuticals
Alkermes
What Amylin's Diabetes Treatment Complete Response Letter Means for Avanir
Seeking Alpha
Thu, 10/21/10 - 11:07 am
Amylin
diabetes
Alkermes
Eli Lilly
Bydureon
Amylin, Lilly, Alkermes Shares Slump as FDA Rejects Bydureon Diabetes Drug
Bloomberg
Wed, 10/20/10 - 10:46 am
Amylin
Eli Lilly
Alkermes
FDA
Bydureon
diabetes
One More Reason That Lilly Must Do A Deal, Fast
Pharmalot
Wed, 10/20/10 - 09:32 am
Eli Lilly
M&A
Amylin
Bydureon
diabetes
Alkermes
Alkermes' Drug Approval On Tap
Investors.com
Tue, 10/19/10 - 10:28 pm
Alkermes
FDA
Bydureon
diabetes
Eli Lilly
Amylin
Byetta
Vivitrol
alcoholism
Update: Perfect FDA Drug Approval Pickers
TheStreet.com
Thu, 10/14/10 - 09:29 am
FDA
Hospira
Human Genome Sciences
Alexza
Jazz Pharmaceuticals
Alkermes
Arena Pharmaceuticals
Amylin
Vivus
Avanir
Forest Labs
Biodel
Don't Get Addicted to Alkermes' Low Revenue
Motley Fool
Wed, 10/13/10 - 04:08 pm
Alkermes
Vivitrol
Titan's Implanted Addiction-Drug Device Works Better Than Placebo in Study
Wed, 10/13/10 - 08:25 am
Titan
drug addiction
Probuphine
buprenorphine
Reckitt Benckiser
Alkermes
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Linjeta
Biodel
Afrezza
MannKind
FDA
Benlysta
Human Genome
GSK
Bydureon
Eli Lilly
Amylin
Alkermes
Brilinta
AstraZeneca
Pradaxa
Boehringer Ingelheim
Qnexa
Vivus
Contrave
Orexigen
ipilimumab
Bristol-Myers Squibb
Merck KGaA
cladribine
Top 5 Upcoming FDA Decisions With Bullish Options Sentiment
Seeking Alpha
Sat, 09/18/10 - 11:07 am
Ista
Alexza
Biodel
Alkermes
Vivus
FDA panel urges wider use for Alkermes drug
Reuters
Fri, 09/17/10 - 11:55 am
FDA
advisory panels
Alkermes
addiction
Vivitrol
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
FDA
Questcor Pharmaceuticals
Savient
Alkermes
Arena Pharmaceuticals
Roche
Novartis
Hospira
Human Genome
Alexza
Jazz Pharmaceuticals
Biodel
Amylin
Eli Lilly
Vivus
Avanir
Cadence Pharmaceuticals
Amgen
Cumberland
Orexigen
MannKind
Bristol-Myers Squibb
Amylin, Alkermes gain ground on Roche drug delay
Yahoo/AP
Fri, 06/18/10 - 11:28 am
Roche
Amylin
Alkermes
diabetes
taspoglutide
Revenues Dip at Alkermes
Yahoo/Zacks.com
Mon, 05/17/10 - 01:34 pm
Alkermes
earnings
Cephalon
JNJ
Alkermes leads drug stocks lower
Marketwatch
Fri, 05/14/10 - 10:03 am
Alkermes
drug stocks
BYDUREON™ FDA Review Timeline Set With PDUFA Action Date Of October 22, 2010
Medical News Today
Sun, 05/9/10 - 12:49 pm
Bydureon
Amylin
Eli Lilly
Alkermes
type 2 diabetes

Pages